glp 1 and cataract surgery The Impact of GLP-1 Receptor Agonists on Ocular Disease Emerging Concerns: GLP-1 Modulators and

GLP-1 receptor agonistsincluding semaglutide, liraglutide, dulaglutide, and exenatideare licensed in the UK for type 2 diabetes management and, in some formulations, for weight management in adults with obesity or overweight with comorbidities

To summarize the last article: GLP-1 medications are reshaping modern medicine because they target the gut-brain-metabolic axis that drives most chronic disease - not just weight loss, but cardiovascular disease, heart failure, kidney disease, neurodegeneration, fatty liver, and systemic inflammation

pharmacy and shipped within 1 business day

Individual results vary based on starting weight, adherence, diet quality, physical activity, and metabolic factors